Serum levels of IL-18 and sIL-2R in patients with alopecia areata receiving combined therapy with oral cyclosporine and steroids

Experimental Dermatology

Volumn 19, Issue 2, 2010, Pages 145-147

  Lee, Deborah ^a   Hong, Soon Kwon ^a   Park, Sung Wook ^b   Hur, Dae Young ^a   Shon, Ji Hong ^a   Shin, Jae Gook ^a   Hwang, Seon Wook ^a   Sung, Ho Suk ^a  

^a Inje University College of Medicine   (South Korea)

^b Sung Wook Park's Dermatology Clinic   (South Korea)

Author keywords

Alopecia areata; IL 18; Prognostic marker; Soluble IL 2 receptor

Indexed keywords

CIPOL N; CYCLOSPORIN A; INTERLEUKIN 18; INTERLEUKIN 2 RECEPTOR; METHYLPREDNISOLONE; SOMERON; UNCLASSIFIED DRUG;

ADULT; ALOPECIA AREATA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG RESPONSE; HUMAN; LETTER; MALE; PROGNOSIS;

ALOPECIA AREATA; CASE-CONTROL STUDIES; CYCLOSPORINE; DERMATOLOGIC AGENTS; HUMANS; INTERLEUKIN-18; PREDNISONE; RECEPTORS, INTERLEUKIN-2;

EID: 74949114441     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.00937.x     Document Type: Letter

References (23)

1. Arca E, Musabak U, Akar A, Erbil A H, Tastan H B. Eur J Dermatol 2004, 14:33-36.
2. Hoffmann R. J Invest Dermatol Symp Proc 1999, 4:235-238.
3. Freyschmidt-Paul P, McElwee K J, Hoffmann R. Br J Dermatol 2006, 155:515-521.
4. Cho W I, Seo S J, Kim M N, Hong C K, Ro B I. Kor J Dermatol 2006, 44:399-404.
5. Teraki Y, Imanishi K, Shiohara T. Acta Derm Venereol 1996, 76:421-423.
6. Shohat M, Mimouni D, Ben-Amitai D. Clin Exp Dermatol 2005, 30:432-434.
7. Kim B J, Min S U, Park K Y. J Dermatol Treat 2008, 19:216-220.
8. Park H H, Sim W Y. J Kor Dermatol 2002, 40:1311-1315.
9. Teshima H, Urabe A, Irie M, Nakagawa T, Nakayama J, Hori Y. Int J Dermatol 1992, 31:513-516.
10. Sun J, Silva K A, McElwee K J, King L E, Sundberg J P. Exp Dermatol 2008, 17:793-805.
11. Ferron G M, Pyszczynski N A, Jusko W L. Transplantation 1998, 65:1203-1209.
12. Rubin L A, Nelson D L. Ann Intern Med 1990, 113:619-627.
13. Dinarello C A. Semin Nephrol 2007, 27:98-114.
14. Flisiak I, Klepacki A, Chodynicka B. Biomarkers 2006, 11:194-200.
15. Cooper K D, Baadsgaard O, Ellis C N, Duell E, Voorhees J J. J Invest Dermatol 1990, 94:649-656.
16. Economidou J, Barkis J, Demetriou Z. Dermatology 1999, 199:144-148.
17. Kapp A, Piskorski A, Schopf E. Br J Dermatol 1988, 119:707-710.
18. Cauducci M, Mussi A, Bonifati C, Fazio M, Ameglio F. Arch Dermatol Res 1994, 286:420-421.
19. de Rie M A, Hamerlinck F, Hintzen R Q, Bos J D, van Lier R A W. Arch Dermatol Res 1991, 283:533-534.
20. Duncan J I, Horrocks C, Ormerod A D. Clin Exp Immunol 1991, 85:293-296.
21. De Rie M A, Zonneveld I M, Witkamp L, Van Lier R A, Out T A, Bos J D. Acta Derm Venereol 1996, 76:357-360.
22. Yamamoto T, Kimura K, Katayama I. Arch Dermatol Res 1996, 289:57-59.
23. Valsecchi R, Imberti G, Martino D, Cainelli T. Dermatology 1992, 184:126-128.